Degradation of Selected Acidic and Neutral Pharmaceutical Products in a Primary-Treated Wastewater by Disinfection Processes

Abstract

Anti-inflammatory and anti-convulsive drugs are being detected in measurable quantities in municipal wastewaters. Some of these emerging substances undergo major transformation at the sewage treatment plant after biological and chemical treatments. The degradation of pharmaceutical products from high-quality treated wastewaters by disinfection processes is well documented. However, the effect of disinfection processes on these products in physicochemical primary-treated municipal effluents remains to be investigated. Pilot projects using ozone, performic acid and UV-radiation disinfection processes were carried out at the Montreal wastewater treatment plant. Residues of pharmaceutical products like salicylic acid, clofibric acid, ibuprofen, naproxen, triclosan, carbamazepine, diclofenac, and 2-hydroxy-ibuprofen were found in the treated wastewaters before disinfection at concentrations ranging from 42 to 2556 ng/L. Most of these substances were eliminated at a rate greater than 50% at an ozone dose of 10 mg/L. Higher removal rates (as high as 70%) were observed when 20 mg/L of ozone was used. Removal rates for UV radiation, on the other hand, were often below 10% among the substances studied. Limited removal rate was observed after UV radiation for diclofenac and triclosan (25 and 40% efficiency, respectively). The irradiation used here (25 mJ/cm²) for bacterial treatment appeared, as previously reported, to be too low to cause the significant breakdown of many of the pharmaceutical substances contained in these wastewaters. Poor reduction efficiencies (< 8%) were observed with the performic acid treatment. Further investigations on analytical methodologies are therefore needed to assess the potential impact of degradation by-products on the environment and on human health.